Immatics NV (Immatics NV) Institutional Ownership : 19.19% (As of May. 22, 2024)

View and export this data going back to 2020. Start your Free Trial

What is Immatics NV Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Immatics NV's institutional ownership is 19.19%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Immatics NV's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Immatics NV's Float Percentage Of Total Shares Outstanding is 79.10%.

Immatics NV Institutional Ownership Historical Data

The historical data trend for Immatics NV's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Immatics NV Institutional Ownership Chart

Immatics NV Historical Data

The historical data trend for Immatics NV can be seen below:

	2023-07-31	2023-08-31	2023-09-30	2023-10-31	2023-11-30	2023-12-31	2024-01-31	2024-02-29	2024-03-31	2024-04-30
Institutional Ownership	10.80	10.69	12.78	12.34	13.07	14.39	12.99	12.96	19.38	19.19

Immatics NV Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

Immatics NV (Immatics NV) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Immatics NV (NAS:IMTX) » Definitions » Institutional Ownership

Comparable Companies

Traded in Other Exchanges

4A3:Germany

Address

Paul-Ehrlich-Strasse 15, Tubingen, BW, DEU, 72076

Website

https://www.immatics.com

Immatics NV is a biotechnology company that is engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies.